Carregant...
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
BACKGROUND: Treatment with angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is used to reduce proteinuria and retard the progression of chronic kidney disease (CKD). However, resolution of proteinuria may be incomplete with these therapies and the addition of a...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2020
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094274/ https://ncbi.nlm.nih.gov/pubmed/33107592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007004.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|